Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifeway Foods ( (LWAY) ) just unveiled an update.
Lifeway Foods, a leader in probiotic kefir products, has rejected Danone’s $27 per share acquisition offer, deeming it undervalued. The company highlights its robust growth and strong financial performance, including a 788% shareholder return over five years and a projected EBITDA of $45-50 million by 2027. Lifeway’s board believes its standalone strategy offers superior value, driven by consumer interest in gut health and operational efficiencies.
See more data about LWAY stock on TipRanks’ Stock Analysis page.

